A new analysis is claiming that the FDA most likely underestimated the number of fetal deaths from Bayer's Essure.
Bayer's breast cancer drug failed to meet its primary endpoint goal in the Phase III trial.
The U.S. Food and Drug Administration has approved the use of anti-cancer drug Nexavar (sorafenib) for late-stage differentiated thyroid cancer. The type is one of the most common kinds of thyroid cancer.
Researchers from the University of Sheffield School of Health and Related Research (ScHARR) are today making a series of recommendations for NHS mental health trusts to change the way they collect and use patient feedback to improve the quality of care for inpatients.